About FDA

FDA Drug Topics: FDA’s MedWatch Adverse Event Reporting Program – Opportunities to Collaborate – March 13, 2018

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!

On Tuesday, March 13, 2018, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: FDA Drug Topics: FDA’s MedWatch Adverse Event Reporting Program – Opportunities to Collaborate. This webinar provided an overview of the Office of Health and Constituent Affairs, identified opportunities to collaborate and advance FDA public health messages and promote public involvement with FDA, described the FDA MedWatch program, demonstrated how to report adverse events to MedWatch and how to obtain safety information.

View Presentation Here: https://collaboration.fda.gov/p8gul0mg48g/

Download Presentation Slides: MedWatch Adverse Event Reporting Program (PDF - 8MB)

Activity Outline and Continuing Education Information: Opportunities to Collaborate (PDF - 227KB)

If you have never attended an Adobe Connect meeting before:

Test your connection: Adobe Connect Diagnostic Test

Get a quick overview: Discover Adobe Connect Solutions

Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.


Page Last Updated: 03/14/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English